sequence stringlengths 4 17.9k | seq_id stringlengths 1 6 | pn stringclasses 996
values | title stringclasses 871
values | pbdt int64 20.2M 20.3M | status int64 1 225 ⌀ | family_country listlengths 1 55 | modified_info stringlengths 112 8.31k ⌀ |
|---|---|---|---|---|---|---|---|
ctgccctcagggatcttgcaa | 2541 | EP4416284A1 | Extra-hepatic delivery irna compositions and methods of use thereof | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
ctgccctcagggatcttgcaa | 2541 | EP4416284A1 | EXTRAHEPATISCHE IRNA-ZUSAMMENSETZUNGEN ZUR ABGABE UND VERFAHREN ZUR VERWENDUNG DAVON | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
ctgccctcagggatcttgcaa | 2541 | EP4416284A1 | COMPOSITIONS D'ARNI À ADMINISTRATION EXTRA-HÉPATIQUE ET LEURS PROCÉDÉS D'UTILISATION | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
gagcacctgcttcatgctcaa | 2128 | EP4416284A1 | Extra-hepatic delivery irna compositions and methods of use thereof | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methylguanosine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["gm"]},{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos... |
gagcacctgcttcatgctcaa | 2128 | EP4416284A1 | EXTRAHEPATISCHE IRNA-ZUSAMMENSETZUNGEN ZUR ABGABE UND VERFAHREN ZUR VERWENDUNG DAVON | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methylguanosine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["gm"]},{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos... |
gagcacctgcttcatgctcaa | 2128 | EP4416284A1 | COMPOSITIONS D'ARNI À ADMINISTRATION EXTRA-HÉPATIQUE ET LEURS PROCÉDÉS D'UTILISATION | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methylguanosine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["gm"]},{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos... |
gagcacctgcttcatgctcaa | 2803 | EP4416284A1 | Extra-hepatic delivery irna compositions and methods of use thereof | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methylguanosine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["gm"]},{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos... |
gagcacctgcttcatgctcaa | 2803 | EP4416284A1 | EXTRAHEPATISCHE IRNA-ZUSAMMENSETZUNGEN ZUR ABGABE UND VERFAHREN ZUR VERWENDUNG DAVON | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methylguanosine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["gm"]},{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos... |
gagcacctgcttcatgctcaa | 2803 | EP4416284A1 | COMPOSITIONS D'ARNI À ADMINISTRATION EXTRA-HÉPATIQUE ET LEURS PROCÉDÉS D'UTILISATION | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methylguanosine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["gm"]},{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos... |
gagcacctgcttcatgctcaa | 2537 | EP4416284A1 | Extra-hepatic delivery irna compositions and methods of use thereof | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
gagcacctgcttcatgctcaa | 2537 | EP4416284A1 | EXTRAHEPATISCHE IRNA-ZUSAMMENSETZUNGEN ZUR ABGABE UND VERFAHREN ZUR VERWENDUNG DAVON | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
gagcacctgcttcatgctcaa | 2537 | EP4416284A1 | COMPOSITIONS D'ARNI À ADMINISTRATION EXTRA-HÉPATIQUE ET LEURS PROCÉDÉS D'UTILISATION | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
gagcacctgcttcatgctcaa | 1860 | EP4416284A1 | Extra-hepatic delivery irna compositions and methods of use thereof | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
gagcacctgcttcatgctcaa | 1860 | EP4416284A1 | EXTRAHEPATISCHE IRNA-ZUSAMMENSETZUNGEN ZUR ABGABE UND VERFAHREN ZUR VERWENDUNG DAVON | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
gagcacctgcttcatgctcaa | 1860 | EP4416284A1 | COMPOSITIONS D'ARNI À ADMINISTRATION EXTRA-HÉPATIQUE ET LEURS PROCÉDÉS D'UTILISATION | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
attcaaactctacttctgtta | 366 | EP4416284A1 | Extra-hepatic delivery irna compositions and methods of use thereof | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
attcaaactctacttctgtta | 366 | EP4416284A1 | EXTRAHEPATISCHE IRNA-ZUSAMMENSETZUNGEN ZUR ABGABE UND VERFAHREN ZUR VERWENDUNG DAVON | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
attcaaactctacttctgtta | 366 | EP4416284A1 | COMPOSITIONS D'ARNI À ADMINISTRATION EXTRA-HÉPATIQUE ET LEURS PROCÉDÉS D'UTILISATION | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
attcaaactctacttctgtta | 636 | EP4416284A1 | Extra-hepatic delivery irna compositions and methods of use thereof | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyladenosine-3'-phosphorothioate","norInfo":[{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O-methyladenosine-3'-phosphorothioate"]},{"norI... |
attcaaactctacttctgtta | 636 | EP4416284A1 | EXTRAHEPATISCHE IRNA-ZUSAMMENSETZUNGEN ZUR ABGABE UND VERFAHREN ZUR VERWENDUNG DAVON | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyladenosine-3'-phosphorothioate","norInfo":[{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O-methyladenosine-3'-phosphorothioate"]},{"norI... |
attcaaactctacttctgtta | 636 | EP4416284A1 | COMPOSITIONS D'ARNI À ADMINISTRATION EXTRA-HÉPATIQUE ET LEURS PROCÉDÉS D'UTILISATION | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyladenosine-3'-phosphorothioate","norInfo":[{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O-methyladenosine-3'-phosphorothioate"]},{"norI... |
ttcattctcattgtcttcacatt | 3681 | EP4416284A1 | Extra-hepatic delivery irna compositions and methods of use thereof | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
ttcattctcattgtcttcacatt | 3681 | EP4416284A1 | EXTRAHEPATISCHE IRNA-ZUSAMMENSETZUNGEN ZUR ABGABE UND VERFAHREN ZUR VERWENDUNG DAVON | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
ttcattctcattgtcttcacatt | 3681 | EP4416284A1 | COMPOSITIONS D'ARNI À ADMINISTRATION EXTRA-HÉPATIQUE ET LEURS PROCÉDÉS D'UTILISATION | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
ttcattctcattgtcttcacatt | 4426 | EP4416284A1 | Extra-hepatic delivery irna compositions and methods of use thereof | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
ttcattctcattgtcttcacatt | 4426 | EP4416284A1 | EXTRAHEPATISCHE IRNA-ZUSAMMENSETZUNGEN ZUR ABGABE UND VERFAHREN ZUR VERWENDUNG DAVON | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
ttcattctcattgtcttcacatt | 4426 | EP4416284A1 | COMPOSITIONS D'ARNI À ADMINISTRATION EXTRA-HÉPATIQUE ET LEURS PROCÉDÉS D'UTILISATION | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
ctatactgtgatgatcacagt | 4077 | EP4416284A1 | Extra-hepatic delivery irna compositions and methods of use thereof | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methylcytidine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["cm"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-... |
ctatactgtgatgatcacagt | 4077 | EP4416284A1 | EXTRAHEPATISCHE IRNA-ZUSAMMENSETZUNGEN ZUR ABGABE UND VERFAHREN ZUR VERWENDUNG DAVON | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methylcytidine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["cm"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-... |
ctatactgtgatgatcacagt | 4077 | EP4416284A1 | COMPOSITIONS D'ARNI À ADMINISTRATION EXTRA-HÉPATIQUE ET LEURS PROCÉDÉS D'UTILISATION | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methylcytidine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["cm"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-... |
ctatactgtgatgatcacagt | 3461 | EP4416284A1 | Extra-hepatic delivery irna compositions and methods of use thereof | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methylcytidine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["cm"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-... |
ctatactgtgatgatcacagt | 3461 | EP4416284A1 | EXTRAHEPATISCHE IRNA-ZUSAMMENSETZUNGEN ZUR ABGABE UND VERFAHREN ZUR VERWENDUNG DAVON | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methylcytidine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["cm"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-... |
ctatactgtgatgatcacagt | 3461 | EP4416284A1 | COMPOSITIONS D'ARNI À ADMINISTRATION EXTRA-HÉPATIQUE ET LEURS PROCÉDÉS D'UTILISATION | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methylcytidine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["cm"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-... |
ctatactgtgatgatcacagt | 3807 | EP4416284A1 | Extra-hepatic delivery irna compositions and methods of use thereof | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
ctatactgtgatgatcacagt | 3807 | EP4416284A1 | EXTRAHEPATISCHE IRNA-ZUSAMMENSETZUNGEN ZUR ABGABE UND VERFAHREN ZUR VERWENDUNG DAVON | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
ctatactgtgatgatcacagt | 3807 | EP4416284A1 | COMPOSITIONS D'ARNI À ADMINISTRATION EXTRA-HÉPATIQUE ET LEURS PROCÉDÉS D'UTILISATION | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
ctatactgtgatgatcacagt | 3191 | EP4416284A1 | Extra-hepatic delivery irna compositions and methods of use thereof | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
ctatactgtgatgatcacagt | 3191 | EP4416284A1 | EXTRAHEPATISCHE IRNA-ZUSAMMENSETZUNGEN ZUR ABGABE UND VERFAHREN ZUR VERWENDUNG DAVON | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
ctatactgtgatgatcacagt | 3191 | EP4416284A1 | COMPOSITIONS D'ARNI À ADMINISTRATION EXTRA-HÉPATIQUE ET LEURS PROCÉDÉS D'UTILISATION | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
gtatcaatattagttggaagt | 1139 | EP4416284A1 | Extra-hepatic delivery irna compositions and methods of use thereof | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
gtatcaatattagttggaagt | 1139 | EP4416284A1 | EXTRAHEPATISCHE IRNA-ZUSAMMENSETZUNGEN ZUR ABGABE UND VERFAHREN ZUR VERWENDUNG DAVON | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
gtatcaatattagttggaagt | 1139 | EP4416284A1 | COMPOSITIONS D'ARNI À ADMINISTRATION EXTRA-HÉPATIQUE ET LEURS PROCÉDÉS D'UTILISATION | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
gtatcaatattagttggaagt | 1406 | EP4416284A1 | Extra-hepatic delivery irna compositions and methods of use thereof | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methylguanosine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["gm"]},{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos... |
gtatcaatattagttggaagt | 1406 | EP4416284A1 | EXTRAHEPATISCHE IRNA-ZUSAMMENSETZUNGEN ZUR ABGABE UND VERFAHREN ZUR VERWENDUNG DAVON | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methylguanosine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["gm"]},{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos... |
gtatcaatattagttggaagt | 1406 | EP4416284A1 | COMPOSITIONS D'ARNI À ADMINISTRATION EXTRA-HÉPATIQUE ET LEURS PROCÉDÉS D'UTILISATION | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methylguanosine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["gm"]},{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos... |
cuuguuaaacaacuuagcuca | 994 | US11208660B1 | Coronavirus iRNA compositions and methods of use thereof | 20,211,228 | 3 | [
"HK",
"US",
"JP",
"CN",
"TW",
"WO",
"EP"
] | null |
acacucuuaacaguauucuua | 923 | US11208660B1 | Coronavirus iRNA compositions and methods of use thereof | 20,211,228 | 3 | [
"HK",
"US",
"JP",
"CN",
"TW",
"WO",
"EP"
] | null |
accuaguaauagguuuccuaa | 1917 | US11208660B1 | Coronavirus iRNA compositions and methods of use thereof | 20,211,228 | 3 | [
"HK",
"US",
"JP",
"CN",
"TW",
"WO",
"EP"
] | null |
accuaguaauagguuuccuaa | 1829 | US11208660B1 | Coronavirus iRNA compositions and methods of use thereof | 20,211,228 | 3 | [
"HK",
"US",
"JP",
"CN",
"TW",
"WO",
"EP"
] | null |
accuaguaauagguuuccuaa | 1033 | US11208660B1 | Coronavirus iRNA compositions and methods of use thereof | 20,211,228 | 3 | [
"HK",
"US",
"JP",
"CN",
"TW",
"WO",
"EP"
] | null |
cgaacuuauguacucauucgu | 290 | US11208660B1 | Coronavirus iRNA compositions and methods of use thereof | 20,211,228 | 3 | [
"HK",
"US",
"JP",
"CN",
"TW",
"WO",
"EP"
] | null |
ccuauuacuagguuccauuguuc | 673 | US11208660B1 | Coronavirus iRNA compositions and methods of use thereof | 20,211,228 | 3 | [
"HK",
"US",
"JP",
"CN",
"TW",
"WO",
"EP"
] | null |
ucggguuugacaguuugaaaagc | 1296 | US11208660B1 | Coronavirus iRNA compositions and methods of use thereof | 20,211,228 | 3 | [
"HK",
"US",
"JP",
"CN",
"TW",
"WO",
"EP"
] | null |
ucggguuugacaguuugaaaagc | 1852 | US11208660B1 | Coronavirus iRNA compositions and methods of use thereof | 20,211,228 | 3 | [
"HK",
"US",
"JP",
"CN",
"TW",
"WO",
"EP"
] | null |
uguacaacuauuguuaaugga | 925 | US11208660B1 | Coronavirus iRNA compositions and methods of use thereof | 20,211,228 | 3 | [
"HK",
"US",
"JP",
"CN",
"TW",
"WO",
"EP"
] | null |
gucugaucccaauauuuaaaaua | 411 | US11208660B1 | Coronavirus iRNA compositions and methods of use thereof | 20,211,228 | 3 | [
"HK",
"US",
"JP",
"CN",
"TW",
"WO",
"EP"
] | null |
cacauagcaaucuuuaaucag | 366 | US11208660B1 | Coronavirus iRNA compositions and methods of use thereof | 20,211,228 | 3 | [
"HK",
"US",
"JP",
"CN",
"TW",
"WO",
"EP"
] | null |
ggugcgagcucuauucuuugcac | 430 | US11208660B1 | Coronavirus iRNA compositions and methods of use thereof | 20,211,228 | 3 | [
"HK",
"US",
"JP",
"CN",
"TW",
"WO",
"EP"
] | null |
auucuugauggaucuggguaagg | 444 | US11208660B1 | Coronavirus iRNA compositions and methods of use thereof | 20,211,228 | 3 | [
"HK",
"US",
"JP",
"CN",
"TW",
"WO",
"EP"
] | null |
caaggaauagcagaaaggcuaaa | 689 | US11208660B1 | Coronavirus iRNA compositions and methods of use thereof | 20,211,228 | 3 | [
"HK",
"US",
"JP",
"CN",
"TW",
"WO",
"EP"
] | null |
gaguacgaacuuauguacuca | 838 | US11208660B1 | Coronavirus iRNA compositions and methods of use thereof | 20,211,228 | 3 | [
"HK",
"US",
"JP",
"CN",
"TW",
"WO",
"EP"
] | null |
gaguacgaacuuauguacuca | 128 | US11208660B1 | Coronavirus iRNA compositions and methods of use thereof | 20,211,228 | 3 | [
"HK",
"US",
"JP",
"CN",
"TW",
"WO",
"EP"
] | null |
gaugguacacuuaugauugaa | 90 | US11208660B1 | Coronavirus iRNA compositions and methods of use thereof | 20,211,228 | 3 | [
"HK",
"US",
"JP",
"CN",
"TW",
"WO",
"EP"
] | null |
gaugguacacuuaugauugaa | 800 | US11208660B1 | Coronavirus iRNA compositions and methods of use thereof | 20,211,228 | 3 | [
"HK",
"US",
"JP",
"CN",
"TW",
"WO",
"EP"
] | null |
uuauuauuggguaaaccuugggg | 1407 | US11208660B1 | Coronavirus iRNA compositions and methods of use thereof | 20,211,228 | 3 | [
"HK",
"US",
"JP",
"CN",
"TW",
"WO",
"EP"
] | null |
uuagaaaccuuuuggcaauguug | 1865 | US11208660B1 | Coronavirus iRNA compositions and methods of use thereof | 20,211,228 | 3 | [
"HK",
"US",
"JP",
"CN",
"TW",
"WO",
"EP"
] | null |
uuagaaaccuuuuggcaauguug | 1948 | US11208660B1 | Coronavirus iRNA compositions and methods of use thereof | 20,211,228 | 3 | [
"HK",
"US",
"JP",
"CN",
"TW",
"WO",
"EP"
] | null |
aaacaccagauggugaaccauug | 399 | US11208660B1 | Coronavirus iRNA compositions and methods of use thereof | 20,211,228 | 3 | [
"HK",
"US",
"JP",
"CN",
"TW",
"WO",
"EP"
] | null |
ucauccaaauccuaaaggauu | 222 | US11208660B1 | Coronavirus iRNA compositions and methods of use thereof | 20,211,228 | 3 | [
"HK",
"US",
"JP",
"CN",
"TW",
"WO",
"EP"
] | null |
aacgaaugaguacauaaguucgu | 646 | US11208660B1 | Coronavirus iRNA compositions and methods of use thereof | 20,211,228 | 3 | [
"HK",
"US",
"JP",
"CN",
"TW",
"WO",
"EP"
] | null |
cuacaucacgaacgcuuucua | 860 | US11208660B1 | Coronavirus iRNA compositions and methods of use thereof | 20,211,228 | 3 | [
"HK",
"US",
"JP",
"CN",
"TW",
"WO",
"EP"
] | null |
uacugaguuggacguguguuuuc | 1088 | US11208660B1 | Coronavirus iRNA compositions and methods of use thereof | 20,211,228 | 3 | [
"HK",
"US",
"JP",
"CN",
"TW",
"WO",
"EP"
] | null |
cuugaggaaguuguagcacgauu | 514 | US11208660B1 | Coronavirus iRNA compositions and methods of use thereof | 20,211,228 | 3 | [
"HK",
"US",
"JP",
"CN",
"TW",
"WO",
"EP"
] | null |
gccacauuuucuaaacucugaag | 633 | US11208660B1 | Coronavirus iRNA compositions and methods of use thereof | 20,211,228 | 3 | [
"HK",
"US",
"JP",
"CN",
"TW",
"WO",
"EP"
] | null |
ccugaucuucugguuuaaaca | 1799 | US11208660B1 | Coronavirus iRNA compositions and methods of use thereof | 20,211,228 | 3 | [
"HK",
"US",
"JP",
"CN",
"TW",
"WO",
"EP"
] | null |
ccugaucuucugguuuaaaca | 1879 | US11208660B1 | Coronavirus iRNA compositions and methods of use thereof | 20,211,228 | 3 | [
"HK",
"US",
"JP",
"CN",
"TW",
"WO",
"EP"
] | null |
uacaggcaaacugaguuggacgu | 1090 | US11208660B1 | Coronavirus iRNA compositions and methods of use thereof | 20,211,228 | 3 | [
"HK",
"US",
"JP",
"CN",
"TW",
"WO",
"EP"
] | null |
acccaauaauacugcgucuua | 1055 | US11208660B1 | Coronavirus iRNA compositions and methods of use thereof | 20,211,228 | 3 | [
"HK",
"US",
"JP",
"CN",
"TW",
"WO",
"EP"
] | null |
ucaccuuauaauucacagaau | 105 | US11208660B1 | Coronavirus iRNA compositions and methods of use thereof | 20,211,228 | 3 | [
"HK",
"US",
"JP",
"CN",
"TW",
"WO",
"EP"
] | null |
uaguuaacuuuaaucucacaa | 889 | US11208660B1 | Coronavirus iRNA compositions and methods of use thereof | 20,211,228 | 3 | [
"HK",
"US",
"JP",
"CN",
"TW",
"WO",
"EP"
] | null |
uuugaggaaguuguagcacgauu | 1224 | US11208660B1 | Coronavirus iRNA compositions and methods of use thereof | 20,211,228 | 3 | [
"HK",
"US",
"JP",
"CN",
"TW",
"WO",
"EP"
] | null |
ccauaccucuauuuagguuguuu | 575 | US11208660B1 | Coronavirus iRNA compositions and methods of use thereof | 20,211,228 | 3 | [
"HK",
"US",
"JP",
"CN",
"TW",
"WO",
"EP"
] | null |
uugccaaaaggcuucuacgca | 349 | US11208660B1 | Coronavirus iRNA compositions and methods of use thereof | 20,211,228 | 3 | [
"HK",
"US",
"JP",
"CN",
"TW",
"WO",
"EP"
] | null |
uugccaaaaggcuucuacgca | 1059 | US11208660B1 | Coronavirus iRNA compositions and methods of use thereof | 20,211,228 | 3 | [
"HK",
"US",
"JP",
"CN",
"TW",
"WO",
"EP"
] | null |
uugccaaaaggcuucuacgca | 1915 | US11208660B1 | Coronavirus iRNA compositions and methods of use thereof | 20,211,228 | 3 | [
"HK",
"US",
"JP",
"CN",
"TW",
"WO",
"EP"
] | null |
cuucuucguaagaacgguaaa | 736 | US11208660B1 | Coronavirus iRNA compositions and methods of use thereof | 20,211,228 | 3 | [
"HK",
"US",
"JP",
"CN",
"TW",
"WO",
"EP"
] | null |
guacugguaagagucauuuua | 971 | US11208660B1 | Coronavirus iRNA compositions and methods of use thereof | 20,211,228 | 3 | [
"HK",
"US",
"JP",
"CN",
"TW",
"WO",
"EP"
] | null |
uuuaguaaggucagucucagucc | 607 | US11208660B1 | Coronavirus iRNA compositions and methods of use thereof | 20,211,228 | 3 | [
"HK",
"US",
"JP",
"CN",
"TW",
"WO",
"EP"
] | null |
uuuaguaaggucagucucagucc | 1317 | US11208660B1 | Coronavirus iRNA compositions and methods of use thereof | 20,211,228 | 3 | [
"HK",
"US",
"JP",
"CN",
"TW",
"WO",
"EP"
] | null |
ucacggacgaaaccguaagcagc | 1258 | US11208660B1 | Coronavirus iRNA compositions and methods of use thereof | 20,211,228 | 3 | [
"HK",
"US",
"JP",
"CN",
"TW",
"WO",
"EP"
] | null |
cacuguacagucuaaaaugua | 928 | US11208660B1 | Coronavirus iRNA compositions and methods of use thereof | 20,211,228 | 3 | [
"HK",
"US",
"JP",
"CN",
"TW",
"WO",
"EP"
] | null |
uguacaacuauuguuaauggu | 215 | US11208660B1 | Coronavirus iRNA compositions and methods of use thereof | 20,211,228 | 3 | [
"HK",
"US",
"JP",
"CN",
"TW",
"WO",
"EP"
] | null |
uaguacgcacacaaucgaagcgc | 1206 | US11208660B1 | Coronavirus iRNA compositions and methods of use thereof | 20,211,228 | 3 | [
"HK",
"US",
"JP",
"CN",
"TW",
"WO",
"EP"
] | null |
aucaggauguaaacuuacaua | 230 | US11208660B1 | Coronavirus iRNA compositions and methods of use thereof | 20,211,228 | 3 | [
"HK",
"US",
"JP",
"CN",
"TW",
"WO",
"EP"
] | null |
aucaggauguaaacuuacaua | 940 | US11208660B1 | Coronavirus iRNA compositions and methods of use thereof | 20,211,228 | 3 | [
"HK",
"US",
"JP",
"CN",
"TW",
"WO",
"EP"
] | null |
caaacugucacuaagaaaucu | 170 | US11208660B1 | Coronavirus iRNA compositions and methods of use thereof | 20,211,228 | 3 | [
"HK",
"US",
"JP",
"CN",
"TW",
"WO",
"EP"
] | null |
agauguuguguacacacacug | 52 | US11208660B1 | Coronavirus iRNA compositions and methods of use thereof | 20,211,228 | 3 | [
"HK",
"US",
"JP",
"CN",
"TW",
"WO",
"EP"
] | null |
guucguuuagagaacagaucuac | 540 | US11208660B1 | Coronavirus iRNA compositions and methods of use thereof | 20,211,228 | 3 | [
"HK",
"US",
"JP",
"CN",
"TW",
"WO",
"EP"
] | null |
uaaucucacauagcaaucuuu | 362 | US11208660B1 | Coronavirus iRNA compositions and methods of use thereof | 20,211,228 | 3 | [
"HK",
"US",
"JP",
"CN",
"TW",
"WO",
"EP"
] | null |
acaauguugcuuuucaaacua | 771 | US11208660B1 | Coronavirus iRNA compositions and methods of use thereof | 20,211,228 | 3 | [
"HK",
"US",
"JP",
"CN",
"TW",
"WO",
"EP"
] | null |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.